Preprint · CC-BY
via OpenAlex
Targeting senescent cells by dasatinib and quercetin ameliorates postmenopausal osteoporosis and rejuvenates bone regeneration.
Ying Wang, LinBin Che, Xi Chen, Zirui He, Dianwen Song, Yuan Yuan, Changsheng Liu
Research Square · 2022
Cellular senescence
Stem-cell exhaustion
Chronic inflammation
Senolytics
Stem-cell therapy
Rat
Human
Abstract
Abstract Clinical therapies developed for estrogen-deficiency-driven postmenopausal osteoporosis (PMO) and related diseases, such as bone degeneration, show multiple adverse effects nowadays. Targeting senescent cells (SnCs) and the consequent senescence(definition)-associated secretory phenotype (SASP) with a combination of dasatinib and quercetin (DQ) is a recently developed novel therapy for multiple age-related diseases. Herein, we found that estrogen deficiency induced-bone loss was attributed to a pro-inflammatory microenvironment with SASP secretions and accelerated SnC accumulation, especially senescent mesenchymal stem cells (MSCs) characterized by exhaustion and dysfunction in middle aged rats. Systematically targeting SnCs with DQ strikingly ameliorated PMO and restored MSC function. Local administration of DQ and BMP2 in combination promoted osteogenic differentiation of MSCs and rejuvenated osteoporotic bone regeneration. Our results repurposed DQ as an attractive therapy for treating PMO and related diseases.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.21203/rs.3.rs-1444778/v1
- Canonical
- link ↗
- Fetched
- 2026-10-28 MST
Cite this
APA
Wang, Y., Che, L., Chen, X., He, Z., Song, D., Yuan, Y., & Liu, C. (2022). Targeting senescent cells by dasatinib and quercetin ameliorates postmenopausal osteoporosis and rejuvenates bone regeneration. <em>Research Square</em>. https://doi.org/10.21203/rs.3.rs-1444778/v1
Vancouver
Wang Y, Che L, Chen X, He Z, Song D, Yuan Y, et al. Targeting senescent cells by dasatinib and quercetin ameliorates postmenopausal osteoporosis and rejuvenates bone regeneration. Research Square. 2022. doi:10.21203/rs.3.rs-1444778/v1.
BibTeX
@unpublished{ying2022Target,
title = {Targeting senescent cells by dasatinib and quercetin ameliorates postmenopausal osteoporosis and rejuvenates bone regeneration.},
author = {Ying Wang and LinBin Che and Xi Chen and Zirui He and Dianwen Song and Yuan Yuan and Changsheng Liu},
journal = {Research Square},
year = {2022},
doi = {10.21203/rs.3.rs-1444778/v1},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Bioactive Materials 2023
Open access · CC-BY
Repurpose dasatinib and quercetin: Targeting senescent cells ameliorates postmenopausal osteoporosis and rejuvenates bone regeneration
Nanomedicine 2026
Preprint · OA
SHED-derived exosomes ameliorate age-related osteoporosis by activating mitophagy in senescent bone marrow mesenchymal stem cells
Figshare 2026
Preprint · CC-BY
SHED-derived exosomes ameliorate age-related osteoporosis by activating mitophagy in senescent bone marrow mesenchymal stem cells
Fundamental Research 2024
Open access · CC-BY
Targeted delivery of liposomal senolytics to alleviate cellular senescence-induced bone loss
Journal of Clinical Densitometry 2007
Citation only
Age-Related Bone Mineral Density, Bone Loss Rate, Prevalence of Osteoporosis, and Reference Database of Women at Multiple Centers in China
Osteoporosis International 2002
Citation only